Flutemetamol F-18

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

The clinical Alzheimer's disease spectrum classified in the A/T/N framework with 18F-Flutemetamol-Centiloid, 18F-MK-6240-CenTauR, and 18F-FDG-AD metaROI: a multicenter memory clinic observational study.

The clinical Alzheimer's disease spectrum classified in the A/T/N framework with 18F-Flutemetamol-Centiloid, 18F-MK-6240-CenTauR, and 18F-FDG-AD metaROI: a multicenter memory clinic observational study.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 12, 2026

Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake.

Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake.

Journal: The journal of prevention of Alzheimer's disease

Published: December 20, 2025

Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.

Machine learning-based prediction of amyloid positivity using early-phase F-18 flutemetamol PET.

Journal: Journal of Alzheimer's disease : JAD

Published: June 24, 2025

Tau PET probes for Alzheimer's disease detection and their structural characterization.

Tau PET probes for Alzheimer's disease detection and their structural characterization.

Journal: Advances in protein chemistry and structural biology

Published: May 05, 2025

Role of Amyloidogenic and Non-Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents.

Role of Amyloidogenic and Non-Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents.

Journal: Chembiochem : a European journal of chemical biology

Published: March 11, 2024

Accuracy of Injection Dose of Amyloid PET Agent Using Radiopharmaceutical Activity Suppliers

Accuracy of Injection Dose of Amyloid PET Agent Using Radiopharmaceutical Activity Suppliers

Journal: Nihon Hoshasen Gijutsu Gakkai zasshi

Published: December 10, 2023

Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes.

Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes.

Journal: Research square

Published: October 16, 2023

Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes.

Amyloid deposition and small vessel disease are associated with cognitive function in older adults with type 2 diabetes.

Journal: Scientific reports

Published: September 20, 2023

Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients.

Lack of association between cortical amyloid deposition and glucose metabolism in early stage Alzheimer´s disease patients.

Journal: Radiology and oncology

Published: October 12, 2021

Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative.

Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative.

Journal: Clinical nuclear medicine

Published: April 22, 2021

Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain.

Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain.

Journal: Nuclear medicine and biology

Published: February 25, 2020

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.

Journal: Brain : a journal of neurology

Published: August 20, 2019

Showing 1-12 of 18

Last Updated: 06/30/2026